Cardlytics Inc (CDLX) is ready for next Episode as it posted an annual sales of 278,300 K

On Friday, Cardlytics Inc (NASDAQ: CDLX) opened lower -7.96% from the last session, before settling in for the closing price of $2.01. Price fluctuations for CDLX have ranged from $1.77 to $15.89 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Communication Services sector company grew by 7.42% over the past five years. Company’s average yearly earnings per share was noted 61.57% at the time writing. With a float of $49.50 million, this company’s outstanding shares have now reached $51.26 million.

Let’s look at the performance matrix of the company that is accounted for 454 employees. In terms of profitability, gross margin is 43.82%, operating margin of -70.19%, and the pretax margin is -68.02%.

Cardlytics Inc (CDLX) Insider Updates

A key investor’s attitude towards the stock of the Advertising Agencies industry is another important factor to consider. The insider ownership of Cardlytics Inc is 4.97%, while institutional ownership is 57.01%. The most recent insider transaction that took place on Feb 19 ’25, was worth 173,462. In this transaction Chief Executive Officer of this company sold 54,565 shares at a rate of $3.18, taking the stock ownership to the 364,072 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Chief Executive Officer sold 46,857 for $3.40, making the entire transaction worth $159,220. This insider now owns 418,637 shares in total.

Cardlytics Inc (CDLX) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 61.57% per share during the next fiscal year.

Cardlytics Inc (NASDAQ: CDLX) Trading Performance Indicators

Check out the current performance indicators for Cardlytics Inc (CDLX). In the past quarter, the stock posted a quick ratio of 1.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.35.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.86, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.36 in one year’s time.

Technical Analysis of Cardlytics Inc (CDLX)

Cardlytics Inc (NASDAQ: CDLX) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 6.95%. Additionally, its Average True Range was 0.26.

During the past 100 days, Cardlytics Inc’s (CDLX) raw stochastic average was set at 2.30%, which indicates a significant decrease from 7.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 117.74% in the past 14 days, which was higher than the 95.80% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.7989, while its 200-day Moving Average is $4.3933. Nevertheless, the first resistance level for the watch stands at $2.0017 in the near term. At $2.1533, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2467. If the price goes on to break the first support level at $1.7567, it is likely to go to the next support level at $1.6633. Assuming the price breaks the second support level, the third support level stands at $1.5117.

Cardlytics Inc (NASDAQ: CDLX) Key Stats

There are currently 52,085K shares outstanding in the company with a market cap of 96.36 million. Presently, the company’s annual sales total 278,300 K according to its annual income of -189,300 K. Last quarter, the company’s sales amounted to 74,000 K and its income totaled -15,590 K.